![Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001567-fx1.jpg)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![Antibody cross-reactivity accounts for widespread appearance of m1A in 5'UTRs | Nature Communications Antibody cross-reactivity accounts for widespread appearance of m1A in 5'UTRs | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-13146-w/MediaObjects/41467_2019_13146_Fig1_HTML.png)
Antibody cross-reactivity accounts for widespread appearance of m1A in 5'UTRs | Nature Communications
Minimizing antibody cross-reactivity in multiplex detection of biomarkers in paper-based point-of-care assays - Nanoscale (RSC Publishing)
![Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic Escherichia coli | Infection and Immunity Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic Escherichia coli | Infection and Immunity](https://journals.asm.org/cms/10.1128/IAI.00246-20/asset/e611ac12-4b63-49f6-ba4f-4b7436c363f5/assets/graphic/iai.00246-20-f0002.jpeg)
Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic Escherichia coli | Infection and Immunity
![Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379120302445-fx1.jpg)
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect
![Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | SpringerLink Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12026-012-8268-8/MediaObjects/12026_2012_8268_Fig1_HTML.gif)
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | SpringerLink
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine](https://www.thelancet.com/cms/attachment/86769381-94ba-420c-91c9-6c2bb6aa8800/gr1_lrg.jpg)
Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine
![T‐cell cross‐reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors - Sioud - 2018 - Scandinavian Journal of Immunology - Wiley Online Library T‐cell cross‐reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors - Sioud - 2018 - Scandinavian Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ef5b53a8-419c-4b6d-95c9-9b4b62a3563d/sji12643-fig-0002-m.jpg)